'About One-Third of Canine Epilepsy Cannot Be Controlled with Medication' - Influencer Vet Dr. Shiwao and Pet Nutritionist Hiromika Explain Latest Care
NQ Score
56/100
AI analysis data is not yet available.
Frequently Asked Questions
- Q: What is the main topic of the Purple Day seminar held by Wellpharma Co., Ltd.?
- A: The main topic of the seminar was 'Epilepsy and Nutrition' for pets, focusing on canine epilepsy and its latest care options.
- Q: Who were the guest speakers at the seminar, and what were their backgrounds?
- A: The guest speakers were Dr. Mitsuhiro Fujiwara (Dr. Shiwao), director of Fujiwara Animal Hospital and an influencer, and pet nutritionist Hiromika.
- Q: What is drug-resistant epilepsy in dogs, and how common is it?
- A: Drug-resistant epilepsy in dogs refers to cases where seizures cannot be sufficiently controlled even with standard anti-epileptic drugs, affecting approximately one-third of canine epilepsy cases.
- Q: What is CBD, and why is it being studied as a new care option for epilepsy?
- A: CBD (cannabidiol) is being studied as a new care option because overseas clinical studies have shown potential in decreasing seizure frequency in epilepsy cases.
- Q: What are some of the symptoms of epilepsy in dogs that were discussed?
- A: Symptoms of epilepsy in dogs discussed included full-body convulsions, loss of consciousness, and localized twitching, all resulting from excessive neuronal excitation in the brain.